These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24614272)

  • 1. Community engagement in diverse populations for Alzheimer disease prevention trials.
    Romero HR; Welsh-Bohmer KA; Gwyther LP; Edmonds HL; Plassman BL; Germain CM; McCart M; Hayden KM; Pieper C; Roses AD
    Alzheimer Dis Assoc Disord; 2014; 28(3):269-74. PubMed ID: 24614272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings.
    Vermunt L; Muniz-Terrera G; Ter Meulen L; Veal C; Blennow K; Campbell A; Carrié I; Delrieu J; Fauria K; Huesa Rodríguez G; Ingala S; Jenkins N; Molinuevo JL; Ousset PJ; Porteous D; Prins ND; Solomon A; Tom BD; Zetterberg H; Zwan M; Ritchie CW; Scheltens P; Luscan G; Brookes AJ; Visser PJ;
    Alzheimers Res Ther; 2020 Jan; 12(1):8. PubMed ID: 31907067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD).
    Walter S; Clanton TB; Langford OG; Rafii MS; Shaffer EJ; Grill JD; Jimenez-Maggiora GA; Sperling RA; Cummings JL; Aisen PS
    J Prev Alzheimers Dis; 2020; 7(4):219-225. PubMed ID: 32920623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Mobile-First Registry to Recruit Healthy Volunteers and Members of Underrepresented Communities for Alzheimer's Disease Prevention Studies.
    Aggarwal R; Sidnam-Mauch E; Neffa-Creech D; Plant A; Williams E; Shami E; Menon U; George S; Langbaum JB
    J Prev Alzheimers Dis; 2023; 10(4):857-864. PubMed ID: 37874108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racially diverse participant registries to facilitate the recruitment of African Americans into presymptomatic Alzheimer's disease studies.
    Cocroft S; Welsh-Bohmer KA; Plassman BL; Chanti-Ketterl M; Edmonds H; Gwyther L; McCart M; MacDonald H; Potter G; Burke JR
    Alzheimers Dement; 2020 Aug; 16(8):1107-1114. PubMed ID: 32543781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Mini-Review of Strategies for Recruiting Older African Americans to Alzheimer's Disease Research.
    Esiaka D; Yarborough CC; Fausto BA; Gluck MA
    Community Health Equity Res Policy; 2024 Jul; 44(4):419-428. PubMed ID: 36120808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Alzheimer's Prevention Registry: A Large Internet-Based Participant Recruitment Registry to Accelerate Referrals to Alzheimer's-Focused Studies.
    Langbaum JB; High N; Nichols J; Kettenhoven C; Reiman EM; Tariot PN
    J Prev Alzheimers Dis; 2020; 7(4):242-250. PubMed ID: 32920626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for the Recruitment and Retention of Racial/Ethnic Minorities in Alzheimer Disease and Dementia Clinical Research.
    Wong R; Amano T; Lin SY; Zhou Y; Morrow-Howell N
    Curr Alzheimer Res; 2019; 16(5):458-471. PubMed ID: 30907319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world Site Experiences With GeneMatch: The Role of a Recruitment-related Registry in the Context of Local Site Effort to Support Alzheimer Disease Prevention Research.
    Bardach SH; Langbaum JB; Kebodeaux CS; Jicha GA
    Alzheimer Dis Assoc Disord; 2021 Apr-Jun 01; 35(2):148-152. PubMed ID: 33273159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing a Memory Clinic Model to Facilitate Recruitment into Early Phase Clinical Trials for Mild Cognitive Impairment and Alzheimer's Disease.
    Park L; Kouhanim C; Lee S; Mendoza Z; Patrick K; Gertsik L; Aguilar C; Gullaba D; Semenova S; Jhee S
    J Prev Alzheimers Dis; 2019; 6(2):135-138. PubMed ID: 30756120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with biomedical research participation within community-based samples across 3 National Cancer Institute-designated cancer centers.
    Barrett NJ; Rodriguez EM; Iachan R; Hyslop T; Ingraham KL; Le GM; Martin K; Haring RC; Rivadeneira NA; Erwin DO; Fish LJ; Middleton D; Hiatt RA; Patierno SR; Sarkar U; Gage-Bouchard EA
    Cancer; 2020 Mar; 126(5):1077-1089. PubMed ID: 31909824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials.
    Vermunt L; Veal CD; Ter Meulen L; Chrysostomou C; van der Flier W; Frisoni GB; Guessous I; Kivipelto M; Marizzoni M; Martinez-Lage P; Molinuevo JL; Porteous D; Ritchie K; Scheltens P; Ousset PJ; Ritchie CW; Luscan G; Brookes AJ; Visser PJ
    Alzheimers Dement; 2018 Jun; 14(6):837-842. PubMed ID: 29604264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing ethnic minority participation in Alzheimer disease research.
    Olin JT; Dagerman KS; Fox LS; Bowers B; Schneider LS
    Alzheimer Dis Assoc Disord; 2002; 16 Suppl 2():S82-5. PubMed ID: 12351920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia.
    Jordan F; Quinn TJ; McGuinness B; Passmore P; Kelly JP; Tudur Smith C; Murphy K; Devane D
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD011459. PubMed ID: 32352165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GeneMatch: A novel recruitment registry using at-home APOE genotyping to enhance referrals to Alzheimer's prevention studies.
    Langbaum JB; Karlawish J; Roberts JS; Wood EM; Bradbury A; High N; Walsh TL; Gordon D; Aggarwal R; Davis P; Stowell C; Trisko L; Langlois CM; Reiman EM; Tariot PN
    Alzheimers Dement; 2019 Apr; 15(4):515-524. PubMed ID: 30772251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of the CHARIOT Research Register for the Prevention of Alzheimer's Dementia and Other Late Onset Neurodegenerative Diseases.
    Larsen ME; Curry L; Mastellos N; Robb C; Car J; Middleton LT
    PLoS One; 2015; 10(11):e0141806. PubMed ID: 26599631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstacles and opportunities in Alzheimer's clinical trial recruitment.
    Watson JL; Ryan L; Silverberg N; Cahan V; Bernard MA
    Health Aff (Millwood); 2014 Apr; 33(4):574-9. PubMed ID: 24711317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial.
    Raman R; Quiroz YT; Langford O; Choi J; Ritchie M; Baumgartner M; Rentz D; Aggarwal NT; Aisen P; Sperling R; Grill JD
    JAMA Netw Open; 2021 Jul; 4(7):e2114364. PubMed ID: 34228129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.